Lbp Am Sa Decreases Stake in Axon Enterprise, Inc $AXON

Lbp Am Sa reduced its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 70.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,621 shares of the biotechnology company’s stock after selling 8,507 shares during the period. Lbp Am Sa’s holdings in Axon Enterprise were worth $2,998,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the stock. LaSalle St. Investment Advisors LLC increased its stake in Axon Enterprise by 2.1% in the 1st quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company’s stock worth $408,000 after purchasing an additional 16 shares during the period. Smartleaf Asset Management LLC increased its stake in Axon Enterprise by 5.0% in the 1st quarter. Smartleaf Asset Management LLC now owns 379 shares of the biotechnology company’s stock worth $203,000 after purchasing an additional 18 shares during the period. Pinion Investment Advisors LLC increased its stake in Axon Enterprise by 3.0% in the 1st quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company’s stock worth $341,000 after purchasing an additional 19 shares during the period. Kentucky Retirement Systems increased its stake in shares of Axon Enterprise by 0.4% during the first quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company’s stock valued at $2,605,000 after buying an additional 19 shares during the period. Finally, WCM Investment Management LLC increased its stake in shares of Axon Enterprise by 0.8% during the first quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company’s stock valued at $1,306,000 after buying an additional 19 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Price Performance

Shares of AXON stock opened at $720.53 on Friday. The stock has a market cap of $56.56 billion, a price-to-earnings ratio of 177.91, a PEG ratio of 27.62 and a beta of 1.41. The business’s fifty day moving average is $758.18 and its 200 day moving average is $706.15. Axon Enterprise, Inc has a twelve month low of $403.16 and a twelve month high of $885.91. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.58. The company had revenue of $668.54 million for the quarter, compared to analysts’ expectations of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm’s revenue for the quarter was up 32.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Research analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Insiders Place Their Bets

In other Axon Enterprise news, Director Jeri Williams sold 100 shares of the business’s stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $752.54, for a total value of $75,254.00. Following the sale, the director directly owned 1,416 shares of the company’s stock, valued at approximately $1,065,596.64. The trade was a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CAO Jennifer H. Mak sold 77 shares of the business’s stock in a transaction on Monday, September 15th. The stock was sold at an average price of $760.00, for a total value of $58,520.00. Following the completion of the sale, the chief accounting officer directly owned 15,003 shares in the company, valued at $11,402,280. This trade represents a 0.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 49,932 shares of company stock valued at $37,978,216. Company insiders own 4.40% of the company’s stock.

Analyst Ratings Changes

AXON has been the topic of several research analyst reports. JPMorgan Chase & Co. boosted their target price on Axon Enterprise from $730.00 to $850.00 and gave the company an “overweight” rating in a research note on Thursday, July 17th. UBS Group reissued a “neutral” rating and set a $840.00 target price (up from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Bank of America boosted their target price on Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Needham & Company LLC reissued a “buy” rating and set a $870.00 target price on shares of Axon Enterprise in a research note on Wednesday, September 24th. Finally, Northland Securities set a $800.00 target price on Axon Enterprise in a research note on Tuesday, August 5th. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $841.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.